Alexei Voloshin is the Global Application Strategy Specialist at 3M Separation and Purification Sciences Division. He is responsible for product application strategy and manages technology projects, collaborations, and alliances around the globe.
Alexei brings more than 15 years of experience in bio-process development, as well as technical, operational, and business knowledge in the biotechnology space.
Before joining 3M, Alexei led molecular diagnostics program at Theranos Inc. He is also a founding member of TheraOne Inc., a start-up company focused on front line cancer immunotherapy. Before TheraOne, Alexei was an early member of Sutro Biopharma Inc., a company focused on development of novel biologics and bio-processes. There he was responsible for technology strategy and process development. He has authored a number of publications and presentations dealing with novel bio-processes and their applications to making advanced bio-therapeutics.
Alexei got his Ph.D. in Chemical Engineering from Stanford University and Bachelor of Chemical Engineering and B.S. in Computer Science from University of Minnesota Twin Cities.